BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

398 related articles for article (PubMed ID: 26195820)

  • 21. ShDcR3 sensitizes TRAIL-resistant HCC cells by inducing caspase-dependent apoptosis while suppressing NF-κB dependent cFLIPL expression.
    Liang DY; Huang W; Chang Q; Hou YQ
    PLoS One; 2018; 13(2):e0191545. PubMed ID: 29444104
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enhanced caspase-8 recruitment to and activation at the DISC is critical for sensitisation of human hepatocellular carcinoma cells to TRAIL-induced apoptosis by chemotherapeutic drugs.
    Ganten TM; Haas TL; Sykora J; Stahl H; Sprick MR; Fas SC; Krueger A; Weigand MA; Grosse-Wilde A; Stremmel W; Krammer PH; Walczak H
    Cell Death Differ; 2004 Jul; 11 Suppl 1():S86-96. PubMed ID: 15105837
    [TBL] [Abstract][Full Text] [Related]  

  • 23. DR5-mediated DISC controls caspase-8 cleavage and initiation of apoptosis in human glioblastomas.
    Bellail AC; Tse MC; Song JH; Phuphanich S; Olson JJ; Sun SY; Hao C
    J Cell Mol Med; 2010 Jun; 14(6A):1303-17. PubMed ID: 19432816
    [TBL] [Abstract][Full Text] [Related]  

  • 24. TRAIL-mediated apoptosis requires NF-kappaB inhibition and the mitochondrial permeability transition in human hepatoma cells.
    Kim YS; Schwabe RF; Qian T; Lemasters JJ; Brenner DA
    Hepatology; 2002 Dec; 36(6):1498-508. PubMed ID: 12447876
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Histone deacetylase inhibitors sensitize glioblastoma cells to TRAIL-induced apoptosis by c-myc-mediated downregulation of cFLIP.
    Bangert A; Cristofanon S; Eckhardt I; Abhari BA; Kolodziej S; Häcker S; Vellanki SH; Lausen J; Debatin KM; Fulda S
    Oncogene; 2012 Nov; 31(44):4677-88. PubMed ID: 22266862
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cellular FLICE/caspase-8-inhibitory protein as a principal regulator of cell death and survival in human hepatocellular carcinoma.
    Okano H; Shiraki K; Inoue H; Kawakita T; Yamanaka T; Deguchi M; Sugimoto K; Sakai T; Ohmori S; Fujikawa K; Murata K; Nakano T
    Lab Invest; 2003 Jul; 83(7):1033-43. PubMed ID: 12861043
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Down-regulation of c-FLIP Enhances death of cancer cells by smac mimetic compound.
    Cheung HH; Mahoney DJ; Lacasse EC; Korneluk RG
    Cancer Res; 2009 Oct; 69(19):7729-38. PubMed ID: 19773432
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CD40 ligand protects from TRAIL-induced apoptosis in follicular lymphomas through NF-kappaB activation and up-regulation of c-FLIP and Bcl-xL.
    Travert M; Ame-Thomas P; Pangault C; Morizot A; Micheau O; Semana G; Lamy T; Fest T; Tarte K; Guillaudeux T
    J Immunol; 2008 Jul; 181(2):1001-11. PubMed ID: 18606651
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The adaptor protein FADD and the initiator caspase-8 mediate activation of NF-κB by TRAIL.
    Grunert M; Gottschalk K; Kapahnke J; Gündisch S; Kieser A; Jeremias I
    Cell Death Dis; 2012 Oct; 3(10):e414. PubMed ID: 23096115
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of RIP and c-FLIP enhances TRAIL-induced apoptosis in pancreatic cancer cells.
    Wang P; Zhang J; Bellail A; Jiang W; Hugh J; Kneteman NM; Hao C
    Cell Signal; 2007 Nov; 19(11):2237-46. PubMed ID: 17693058
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Unique resistance of breast carcinoma cell line T47D to TRAIL but not anti-Fas is linked to p43cFLIP(L).
    Guseva NV; Rokhlin OW; Taghiyev AF; Cohen MB
    Breast Cancer Res Treat; 2008 Feb; 107(3):349-57. PubMed ID: 17453339
    [TBL] [Abstract][Full Text] [Related]  

  • 32. cFLIP
    Davidovich P; Higgins CA; Najda Z; Longley DB; Martin SJ
    Cell Rep; 2023 Dec; 42(12):113476. PubMed ID: 37988267
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Overexpression of Par-4 sensitizes TRAIL-induced apoptosis via inactivation of NF-kappaB and Akt signaling pathways in renal cancer cells.
    Lee TJ; Jang JH; Noh HJ; Park EJ; Choi KS; Kwon TK
    J Cell Biochem; 2010 Apr; 109(5):885-95. PubMed ID: 20127709
    [TBL] [Abstract][Full Text] [Related]  

  • 34. RIP1 modulates death receptor mediated apoptosis and autophagy in macrophages.
    Yao Z; Zhang P; Guo H; Shi J; Liu S; Liu Y; Zheng D
    Mol Oncol; 2015 Apr; 9(4):806-17. PubMed ID: 25583602
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regulation of the resistance to TRAIL-induced apoptosis in human primary T lymphocytes: role of NF-kappaB inhibition.
    Morales JC; Ruiz-Magaña MJ; Ruiz-Ruiz C
    Mol Immunol; 2007 Apr; 44(10):2587-97. PubMed ID: 17257681
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Y14 positively regulates TNF-α-induced NF-κB transcriptional activity via interacting RIP1 and TRADD beyond an exon junction complex protein.
    Togi S; Shiga K; Muromoto R; Kato M; Souma Y; Sekine Y; Kon S; Oritani K; Matsuda T
    J Immunol; 2013 Aug; 191(3):1436-44. PubMed ID: 23817415
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lipid rafts and nonrafts mediate tumor necrosis factor related apoptosis-inducing ligand induced apoptotic and nonapoptotic signals in non small cell lung carcinoma cells.
    Song JH; Tse MC; Bellail A; Phuphanich S; Khuri F; Kneteman NM; Hao C
    Cancer Res; 2007 Jul; 67(14):6946-55. PubMed ID: 17638906
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Targeting A20 enhances TRAIL-induced apoptosis in hepatocellular carcinoma cells.
    Dong B; Lv G; Wang Q; Wei F; Bellail AC; Hao C; Wang G
    Biochem Biophys Res Commun; 2012 Feb; 418(2):433-8. PubMed ID: 22285182
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Down-regulation of RIP1 by 2-deoxy-D-glucose sensitizes breast cancer cells to TRAIL-induced apoptosis.
    Huang YY; Liu H; Li Y; Pu LJ; Jiang CC; Xu JC; Jiang ZW
    Eur J Pharmacol; 2013 Apr; 705(1-3):26-34. PubMed ID: 23499682
    [TBL] [Abstract][Full Text] [Related]  

  • 40. RIP1 is a central signaling protein in regulation of TNF-α/TRAIL mediated apoptosis and necroptosis during Newcastle disease virus infection.
    Liao Y; Wang HX; Mao X; Fang H; Wang H; Li Y; Sun Y; Meng C; Tan L; Song C; Qiu X; Ding C
    Oncotarget; 2017 Jun; 8(26):43201-43217. PubMed ID: 28591723
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.